Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08ZIS
|
|||
Former ID |
DNC009668
|
|||
Drug Name |
4-(2-thienyl)benzene-1,2-diamine
|
|||
Synonyms |
4-(thiophen-2-yl)benzene-1,2-diamine; 471239-63-1; 4-(2-thienyl)-1,2-Benzenediamine; CHEMBL495702; SCHEMBL2873589; XWTMGMKBRLLEFX-UHFFFAOYSA-N; MolPort-042-605-637; ZINC40977399; AKOS033921192; DA-05644; FT-0738633
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H10N2S
|
|||
Canonical SMILES |
C1=CSC(=C1)C2=CC(=C(C=C2)N)N
|
|||
InChI |
1S/C10H10N2S/c11-8-4-3-7(6-9(8)12)10-2-1-5-13-10/h1-6H,11-12H2
|
|||
InChIKey |
XWTMGMKBRLLEFX-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated potassium channel Kv11.1 (KCNH2) | Target Info | Inhibitor | [1] |
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Voltage gated Potassium channels | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Hematopoietic Stem Cell Differentiation | ||||
Potassium Channels |
References | Top | |||
---|---|---|---|---|
REF 1 | Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1168-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.